Ways Douglas Kirk — SEC Form 4 filings

SEC reporting owner CIK 1869391. 3 Form 4 filings on record with FilingPulse; latest filed 2026-01-21.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-05-24 to 2026-01-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
SPRUCE BIOSCIENCES, INC. (SPRB)Interim Chief Medical Officer, Director39

Form 4 filings — Ways Douglas Kirk

FiledFormIssuerReported transactionsSource
2026-01-214SPRUCE BIOSCIENCES, INC. (SPRB)Option exercise (M): 1,250 @ $0 · Grant/award (A): 5,000 (derivative) @ $0 · Option exercise (M): 1,250 (derivative) @ $0 · Grant/award (A): 266 (derivative) · Disposition to issuer (D): 266 (derivative) · Grant/award (A): 400 (derivative) · +1 moreEDGAR
2025-07-244SPRUCE BIOSCIENCES, INC. (SPRB)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-05-244SPRUCE BIOSCIENCES, INC. (SPRB)Grant/award (A): 30,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1869391 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →